跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 112 条关于
“Amgros”
全部
112
临床试验
48
药物
9
机构
11
资讯
44
2年前
UK and Denmark Approve CSL's Hemgenix Gene Therapy for Haemophilia B with Novel Reimbursement Models
去年
Victor Ambros and Gary Ruvkun Awarded Nobel Prize for microRNA Discovery
5个月前
Ambros Therapeutics Secures Key Patent for Precision Medicine Approach to Treating Complex Regional Pain Syndrome
9个月前
Ambros Therapeutics Launches with $125M to Advance Non-Opioid Pain Drug Neridronate for Rare Disease CRPS-1
28天前
Werewolf and Ambros Therapeutics Announce Merger to Advance Neridronate as Potential First FDA-Approved Treatment for CRPS-1
去年
FDA Requires Label Update for Agios Pharmaceuticals' Pyrukynd
去年
Omeros' Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy
去年
Omeros' Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy
8个月前
Omeros Receives FDA Approval for First-in-Class TA-TMA Therapy YARTEMLEA
去年
FDA Grants Rare Pediatric Disease Designation to Omeros' Zaltenibart for C3 Glomerulopathy
第 1 页,共 5 页
上一页
下一页